SLC5A2 and type 2 diabetes mellitus: In agreement with our results, Majid et al. conducted a systematic review and meta-analysis that included five studies to evaluate the effects of Ramadan fasting on patients with T2DM treated with SGLT2 inhibitors and showed that HbA1c was significantly lower after Ramadan than before Ramadan [17].